PARI Named Leading Nebulizer Company in Cambridge Consulting Survey; Market Dominance Also Visible with Frost & Sullivan Award for Product Innovation

Midlothian, Virginia, June 19, 2006 – In its recently released study of the global nebulizer market, Cambridge Consulting named PARI the market dominator for high-end, differentiated
nebulizers in the United States and Germany. This follows the September Frost & Sullivan Product Differentiation Innovation Award for PARI’s TREK compressor nebulizer system. Both
the recognition as the market leader and the award for innovative technology speak to PARI’s continuing commitment to improve the lives of people afflicted with respiratory disease.

Cambridge Consulting’s 2006 survey noted that global nebulizer market revenues are expected to grow from $288.5 million to $398.4 million in 2110. In the two largest markets in Europe and the Americas, PARI was named the market leader for differentiated nebulizers mainly used to treat asthma, COPD, and cystic fibrosis.

“This year is a time for celebration at PARI. In May we are marking our 100th anniversary, and we are thrilled to be recognized again as the market leader for advancing nebulizer science and providing quality products that enhance patient’s lives. Every day we are developing new and improved products for a wide variety of diseases and are pleased that the market prefers our nebulizer and compressor systems for respiratory therapies,” said Werner Gutmann, president
of PARI Respiratory Equipment.

PARI Respiratory was also recognized with the Frost and Sullivan award for product differentiation for its TREK nebulizer system. The TREK was given the award because:

• TREK family of products provided a significant improvement over similar products offered by competitors in this segment

• After introduction, PARI saw a directly related positive impact on sales

• TREK provides great benefit to end-users due to product differentiation.

• It is easy to use and very effective – qualities that provide ease of adaptability for new end-user applications.

The TREK is a lightweight, portable compressor system that can be used with PARI nebulizers
and masks.

About PARI Respiratory Equipment

PARI Respiratory Equipment is the North American arm of PARI Gmbh. PARI is a leading worldwide developer and manufacturer of fast and efficient aerosol delivery systems for patients with asthma, chronic lung disease, and cystic fibrosis.

PARI's primary focus is to provide patients with innovative products and services that help control disease. Products available include breath enhanced, reusable nebulizers including the PARI LC PLUS and PARI LC STAR, masks like PARI Baby, as well as compressor/nebulizer systems including
the PARI PRONEB Ultra and PARI Trek. PARI is headquartered in Starnberg, Germany with a major presence in the United States and offices in Japan, United Kingdom, and China. Online
at www.Pari.com.

Additional information is available by contacting Norm Tiffin at 519-869-8344.